Add to MyYahoo RSS

Topamax, Topiramate News

News on Topamax, Topiramate (generic) continually updated from thousands of sources around the net.

Thursday Aug 21 | BioSpace

Supernus Pharmaceuticals Announces Paragraph IV Anda Filing for Trokendi XR

Supernus Pharmaceuticals, Inc. today announced that on August 20, 2014, the Company received a Paragraph IV Notice Letter from Actavis Laboratories FL, Inc. advising Supernus of the filing by Actavis of an Abbreviated New Drug Application seeking approval for topiramate extended-release capsules.


Related Topix: Medicine, Healthcare Law, Law, Epilepsy, Health

Tue Aug 19, 2014


Supernus to Attend FBR HealthCare Conference in September

Supernus Pharmaceuticals, Inc. , a specialty pharmaceutical company, today announced that the Company's management will be hosting investor meetings during the FBR Healthcare Conference.


Related Topix: Epilepsy, Medicine, Health, Trileptal, Oxcarbazepine (generic)

Mon Aug 18, 2014

Medical News Today

Combination weight loss drugs hard to tolerate, but efficacious

Soon-to-be-available combination medication may be a viable option for obese Australians seeking to lose weight and maintain the loss, but only if they can manage its adverse effects, according to research published in the Medical Journal of Australia .


Related Topix: Medicine, Phentermine (generic), Ionamin, Adipex-P, Epilepsy, Health

Wed Aug 13, 2014

The San Diego Union-Tribune

Off-Label Squabble

Should a pharmaceutical sales rep be allowed to tell a doctor that Topamax, a drug approved to treat seizures and prevent migraine headaches, might also help combat alcohol dependence? Or suggest the epilepsy drug Neurontin could also help treat bipolar disorders or insomnia? Or offer data showing that any number of other drugs could have uses ... (more)


Related Topix: Medicine, Seizures, Health, Epilepsy, Marketing, Healthcare Law, Law, Food and Drug Administration

Mon Jul 28, 2014


The Upsher-Smith Laboratories Galaxy??? Portfolio Of Antiepileptic Drugs Now Available

The current Upsher-Smith Galaxy Portfolio includes seven frequently prescribed AEDs which represent more than one out of every three prescriptions written for seizure disorders.1 The launch of the Upsher-Smith Galaxy demonstrates the company's commitment to simplifying access to effective treatments and reducing healthcare costs.


Related Topix: Epilepsy, Medicine, Health, Seizures